SAN FRANCISCO--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Artisan Development Labs Inc. (DBA Artisan Bio), an immune cell engineering company developing next-generation cell therapies, today announced a collaboration to discover novel antibodies against five undisclosed targets, with an option to expand with additional targets.
Should Johnson & Johnson ($JNJ) join the Big Pharma split-up club? One of its major shareholders thinks so, and it's pressing activist investors to join the cause.